The Week In Weed: June 24, 2022

SS
Seyfarth Shaw LLP

Contributor

With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
United States Cannabis & Hemp

Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.

This week, we look at the Justice Department's action (or lack thereof) on cannabis. In other inaction news, the Supreme Court will not take up a medical marijuana case. Turning to the states, we see that Maryland is working on rules for a possible cannabis market. In Texas meanwhile, the state's Republican party came out strongly against such action. And finally, election season has brought us "pot for potholes."

department of justice

We all know that cannabis is illegal on the federal level. We also know that the Justice Department has not emphasized enforcement in states where cannabis is legal. Different administrations have taken different stances on how clear that "hands-off" approach should be. The Obama Administration formalized it with the Cole Memorandum; the Trump Administration rescinded that guidance. So where does the Biden Administration stand? Attorney General Merrick Garland indicated recently that he did not view prosecution of low-level, nonviolent marijuana offenses as the best use of the agency's time, regardless of state law. He also promised that the department would address the issue "in the days ahead."

supreme court

The U.S. Supreme Court declined to hear two cases involving reimbursement for medical marijuana treatment. The Minnesota Supreme Court had ruled that the Controlled Substances Act preempts state law on the issue. SCOTUS's decision not to hear the cases means that ruling will remain the law of the land (of 10,000 lakes).

maryland

In November, Maryland voters will decide whether adult-use marijuana will be legal in the state. State lawmakers, assuming the answer will be "yes," started gathering some information about the industry. The Maryland House Cannabis Referendum and Legalization Workgroup met with John Hudak, a senior fellow and cannabis policy expert at the Brookings Institution. They asked questions concerning tax rates and application fees, among other issues.

texas

The Texas Republican Party met recently to vote on its party platform. Cannabis/marijuana was mentioned in the document. The party supports moving cannabis from Schedule I to Schedule II on the federal level. It also opposed the legalization of recreational marijuana.

and finally

Speaking of elections, not all Republicans are on board with the anti-legalization stance in Texas. C.W. Gardner, a GOP Senate candidate from Missouri, has a new ad out that advocates federal legalization. He'd like to take some of the tax revenue to fix America's roads. Because, no matter your stance on pot, no one likes potholes.

Stay safe and be well everyone - we'll see you next week!

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More